NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-080-2018-0-JP-08 NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY JP National Stage 2020-542544 Issued
NICHD E-173-2016-0-US-07 MULTI-DIMENSIONAL SPECTROSCOPIC NMR AND MRI USING MARGINAL DISTRIBUTIONS US National Stage 16/324,413 11415652 Issued PDF
NCATS E-229-2016-0-US-04 PEPTIDE INHIBITORS OF PHOSPHOGLYCERATE MUTASE AND METHODS OF USE US National Stage 16/324,424 10808010 Issued PDF
NIAID E-099-2016-1-US-04 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US DIV 16/271,577 10668114 Issued PDF
NIAID E-099-2016-1-US-03 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US DIV 16/271,552 10500238 Abandoned PDF
NCI E-080-2018-0-PCT-02 NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY PCT PCT PCT/US2019/017354 Expired
NCI E-041-2018-0-PCT-02 A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER PCT PCT PCT/US2019/017239 Expired
NCI E-080-2018-0-CN-05 NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY CN National Stage 201980012620.8 Pending
NCI E-041-2018-0-EP-03 A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER EP National Stage 19707221.8 Pending
NCI E-080-2018-0-EP-06 NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY EP National Stage 19707555.9 Pending
NCI E-080-2018-0-CA-04 NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY CA National Stage 3089396 Pending
NCI E-080-2018-0-IN-07 NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY IN National Stage 202037038092 Pending
NCI E-080-2018-0-AU-03 NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY AU National Stage 2019216781 Pending
NICHD E-173-2016-0-JP-06 MULTI-DIMENSIONAL SPECTROSCOPIC NMR AND MRI USING MARGINAL DISTRIBUTIONS JP National Stage 2019-506625 Issued
NCI E-068-2018-0-PCT-02 TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 PCT PCT PCT/US2019/016975 Expired
NCI E-245-2016-0-US-05 NEAR-IR LIGHT-CLEAVABLE CONJUGATES AND CONJUGATE PRECURSORS US National Stage 16/323,747 10561729 Issued PDF
NIDA E-023-2018-0-PCT-02 DREADD ACTUATORS PCT PCT PCT/US2019/016892 Expired
NICHD E-173-2016-0-EP-05 MULTI-DIMENSIONAL SPECTROSCOPIC NMR AND MRI USING MARGINAL DISTRIBUTIONS EP National Stage 17755012.6 Issued
NICHD E-173-2016-0-GB-01 MULTI-DIMENSIONAL SPECTROSCOPIC NMR AND MRI USING MARGINAL DISTRIBUTIONS GB EP 17755012.6 Issued
NCI E-106-2018-0-US-02 Use Of Cell Permeable Inhibitors Of Tyrosyl-DNA Phosphodiesterase 2 (TDP2) To Potentiate TOP2 Inhibitors As Anticancer Agents US ORD 16/267,274 10617706 Issued PDF
NCI E-211-2016-0-US-05 MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 (GPC2) AND USE THEREOF US National Stage 16/322,712 11066479 Issued PDF
NINDS E-252-2016-1-EP-02 Diagnosing COL6-Related Disorders And Methods For Treating Same EP National Stage 17824810.0 Pending
NCI E-767-2013-0-EP-11 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules EP DIV 19154412.1 Pending
NCI E-215-2017-0-CA-04 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES CA National Stage 3088410 Issued
NCI E-215-2017-0-JP-06 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES JP National Stage 2020-542077 Issued
NCI E-215-2017-0-EP-05 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES EP National Stage 19705051.1 Issued
NCI E-215-2017-0-IT-01 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES IT EP 19705051.1
NCI E-215-2017-0-GB-01 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES GB EP 19705051.1 Issued
NCI E-215-2017-0-CH-01 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES CH EP 19705051.1 Issued
NCI E-215-2017-0-ES-01 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES ES EP 19705051.1
NCI E-215-2017-0-FR-01 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES FR EP 19705051.1 Issued
NCI E-215-2017-0-DE-01 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES DE EP 19705051.1 Issued
NCI E-215-2017-0-AU-03 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES AU National Stage 2019216241 Issued
NCI E-175-2016-0-EP-06 ANTI-KRAS-G12D T CELL RECEPTORS EP National Stage 17749580.1 Issued
NCI E-231-2015-0-US-09 NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) OF SUPPRESSOR CELLS TO TREAT CANCER US National Stage 15/749,028 11013803 Issued PDF
NCI E-175-2016-0-US-08 ANTI-KRAS-G12D T CELL RECEPTORS US National Stage 16/321,899 10611816 Issued PDF
NCI E-215-2017-0-PCT-02 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES PCT PCT PCT/US2019/015763 Expired
CC E-096-2016-0-US-03 POWERED GAIT ASSISTANCE SYSTEMS US National Stage 16/321,565 11801153 Issued PDF
NIMH E-448-2013-0-US-06 Antineuronal Antibodies In Pediatric Acute Neurologic Syndrome For Diagnosis And Treatment US CON 16/259,062 Abandoned
CC E-277-2015-0-US-04 Sensorless Transperineal Ultrasound-MRI Fusion Guided Prostate Biopsy US National Stage 16/320,980 11504154 Issued PDF
NCI E-119-2013-0-US-04 A Technology And Prototype Of An Automated Instrument For The Synthesis Of Selectively Labeled RNA At Specific Residue(s) And/or Specific Segment(s) US CON 16/258,021 Pending
NCI E-115-2016-0-US-03 Fluorine-18 Labeling Of Peptide For PET Imaging Study Of Over-expression Of C-MET US National Stage 16/320,645 Abandoned
NEI E-044-2018-0-US-02 EXOSOMES AND MIRNA TO TREAT GLAUCOMA US ORD 16/257,026 11058729 Issued PDF
NCI E-175-2016-0-SG-11 ANTI-KRAS-G12D T CELL RECEPTORS SG National Stage 11201900654Q Pending
NICHD E-173-2016-0-AU-03 MULTI-DIMENSIONAL SPECTROSCOPIC NMR AND MRI USING MARGINAL DISTRIBUTIONS AU National Stage 2017310513 Issued
NHLBI E-121-2016-1-JP-04 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE JP National Stage 2019-503538 Issued
NINDS E-009-2019-0-US-01 Automated Identification Of Subjects At Risks Of Multiple Sclerosis (AIMS) US ORD 16/254,710 11272843 Issued PDF
NCI E-105-2012-0-AT-28 MURINE ANTI-NY-ESO-1 T CELL RECEPTORS AT EP 19152955.1 Issued
NCI E-105-2012-0-IT-36 Murine Anti-NY-ESO-1 T Cell Receptors IT EP 19152955.1 Issued
NCI E-105-2012-0-IE-35 Murine Anti-NY-ESO-1 T Cell Receptors IE EP 19152955.1 Issued